In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Nitric oxide synthesis is declined in cardiovascular and metabolic diseases associated with endothelial dysfunction such as type 2 diabetes, hypertension or congestive heart failure. The objectives were to validate a novel stable isotopic method for the determination of in-vivo nitric oxide synthesis and to evaluate differences in nitric oxide synthesis in obese patients with and without metabolic syndrome (MetSyn). METHODS: The new method, called oral nitrate test (ONT), measured the decay in saliva or urine samples of an oral dose of labelled sodium nitrate. The ONT method was compared to a validated method (frequent sampling arginine test, FSAT method) in 10 healthy adult volunteers (BMI range = 20.8-27.3 kg/m). The accuracy of the saliva ONT method was then tested by measuring nitric oxide synthesis in seven healthy, normal weight individuals, seven obese patients without MetSyn and seven obese patients with MetSyn. RESULTS: The estimated rate of nitric oxide synthesis was 0.63 ± 0.20 μmol/h per kg from the data obtained from saliva, and 0.50 ± 0.14 μmol/h per kg from urine. The agreement of the saliva ONT method with the FSAT method (Δ = +0.02 ± 0.24; P = 0.79) was superior to the urine ONT method (Δ = -0.11 ± 0.20; P = 0.13). Obese patients with MetSyn had a significantly lower nitric oxide production rate (0.21 ± 0.13 μmol/h per kg; P = 0.009) than healthy normal weight individuals (0.63 ± 0.30 μmol/h per kg), whereas nitric oxide production rate was intermediate in obese patients without MetSyn (0.49 ± 0.22 μmol/h per kg; P = 0.33). CONCLUSION: The advantages of the new saliva ONT method are its accuracy, sensitivity and lack of invasiveness, which could make it a reference method for the assessment of in-vivo rates of whole-body nitric oxide synthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NO modulates insulin signalling pathways in muscle cells80, while obesity and metabolic syndrome are associated with decreased whole-body NO synthesis81.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [81]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Nitric Oxide and Peroxynitrite in Health and Disease
Pacher, P., Beckman, J. S., & Liaudet, L. (2007) · Physiological Reviews · doi:10.1152/physrev.00029.2006 · Cited by 6,390
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Nitric oxide metabolism and breakdown
Kelm, M. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00020-1 · Cited by 673
Mechanisms of homocysteine-induced oxidative stress
Tyagi, N., Sedoris, K. C., Steed, M., Ovechkin, A. V., Moshal, K. S., & Tyagi, S. C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00548.2005 · Cited by 435
Nitric oxide deficiency in chronic kidney disease
Baylis, C. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00424.2007 · Cited by 413
Research works printed but not linked: 1
- Ellger, 2008, Modulation of regional nitric oxide metabolism: blood glucose control or insulin Intensive Care M, ed, 34, 1525
Cited by
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“NO modulates insulin signalling pathways in muscle cells 80 , while obesity and metabolic syndrome are associated with decreased whole-body NO synthesis 81 .”
Self-citationNitrate and Nitrite in Health and Disease
Ma, L., Hu, L., Feng, X., & Wang, S. (2018) · Aging and disease · doi:10.14336/ad.2017.1207 · Cited by 294
“Under conditions of illness or senescence, the activity of eNOS was reduced and the production of NO was decreased, as reported [46, 66, 67], thus indicating exogenous source of NO supplement might have a potential therapeutic treatment for patients undergoing illness or senescence.”
BackgroundRoberts, L. D., Ashmore, T., Kotwica, A. O., Murfitt, S. A., Fernandez, B. O., Feelisch, M., Murray, A. J., & Griffin, J. L. (2015) · Diabetes · doi:10.2337/db14-0496 · Cited by 145
“The identification of an enhanced capacity for nitrate to induce the browning response of WAT in lowoxygen conditions through NO, which will likely also contribute to improved vascular health in obese individuals where NO production is decreased (46), may represent a significant therapeutic opportunity to partly rever…”
BackgroundBersani, F. S., Wolkowitz, O. M., Lindqvist, D., Yehuda, R., Flory, J., Bierer, L. M., Makotine, I., Abu-Amara, D., Coy, M., Reus, V. I., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.015 · Cited by 84
“, 2014]) can themselves be associated with lowered NO production (Huang, 2009; Siervo et al., 2011).”
Dietary inorganic nitrate: From villain to hero in metabolic disease?
McNally, B., Griffin, J. L., & Roberts, L. D. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500153 · Cited by 80
“Furthermore, obese individuals were found to have a decreased capacity for NO production [66].”
Background
Metadata
- Authors
- Siervo, M., Jackson, S. J., & Bluck, L. J. C.
- Affiliations
- MRC Elsie Widdowson Laboratory (GB)
- Corresponding author
- Bluck, Les J.C.
- Venue
- Journal of Hypertension
- Published
- 2011-08
- Volume
- 29
- Issue
- 8
- Pages
- 1515-1527
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1965369215
- Cited by
- 44
- References
- 50
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 5 · 2019: 2 · 2018: 6 · 2017: 2 · 2016: 6 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- nitric oxide production, metabolic syndrome, obesity, stable isotope tracers, endothelial dysfunction
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Diagnostic Tests, Routine, Female, Heart Failure, Humans, Hypertension, Isotopes, Male, Middle Aged, Models, Theoretical, Nitrates, Nitric Oxide, Obesity, Saliva, Sensitivity and Specificity, Reproducibility of Results, Comorbidity, Case-Control Studies, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. https://app.cochat.ai/papers/10.1097/hjh.0b013e3283487806
- The paper
- Siervo, M., Jackson, S. J., & Bluck, L. J. C. (2011). In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3283487806
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.